Detalles de la búsqueda
1.
M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
Oncologist
; 24(8): e749-e754, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30696724
2.
Pembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report.
Clin Exp Dermatol
; 48(9): 1077-1080, 2023 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37119266
3.
Algorithm-based decision support for symptom self-management among adults with Cancer: results of usability testing.
BMC Med Inform Decis Mak
; 18(1): 31, 2018 05 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29843767
4.
Clinician perspectives on symptom and quality of life experiences of patients during cancer therapies: Implications for eHealth.
Psychooncology
; 26(8): 1113-1119, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28497471
5.
Patient and caregiver perspectives on decision support for symptom and quality of life management during cancer treatment: Implications for eHealth.
Psychooncology
; 26(8): 1105-1112, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28430396
6.
Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progression.
Cancer
; 119(21): 3761-8, 2013 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23922022
7.
RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: comparison with RECIST 1.0.
AJR Am J Roentgenol
; 201(1): W64-71, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23789698
8.
First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions.
J Natl Compr Canc Netw
; 10(7): 847-56, 2012 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22773800
9.
Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature.
JTO Clin Res Rep
; 3(11): 100415, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36275908
10.
Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse.
JCO Precis Oncol
; 6: e2100522, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35584349
11.
Clinical Decision Support for Symptom Management in Lung Cancer Patients: A Group RCT.
J Pain Symptom Manage
; 63(4): 572-580, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921934
12.
Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer.
Cancer Res
; 81(9): 2566-2573, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653773
13.
High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor Content.
JCO Precis Oncol
; 52021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250382
14.
Identification of a RAS-activating TMEM87A-RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(15): 4072-4079, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32312893
15.
Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis.
JCO Precis Oncol
; 42020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33015530
16.
Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.
Eur J Radiol Open
; 6: 128-131, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30984804
17.
Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation.
JCO Precis Oncol
; 7: e2200633, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37384867
18.
Outcomes by EGFR, KRAS, and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 2: 1-18, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135121
19.
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.
JAMA Oncol
; 4(11): 1527-1534, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30073261
20.
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.
Clin Cancer Res
; 12(13): 3908-14, 2006 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16818686